"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...
Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a ...
2d
StudyFinds on MSNPersonalized vaccines halt kidney cancer after encouraging phase 1 trialGroundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...
A phase 1 trial of a personalized cancer vaccine for stage III/IV clear cell renal cell carcinoma showed promising results.
According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results